Literature DB >> 33534038

Multimodality In Vivo Imaging of Perfusion and Glycolysis in a Rat Model of C6 Glioma.

Qi Qi1,2,3, Matthew S Fox3,4, Heeseung Lim1,5, Robert Bartha1,5,6, Timothy J Scholl1,2,5,7, Lisa Hoffman1,3,8, Ting-Yim Lee1,2,3,5,6, Jonathan D Thiessen9,10,11,12.   

Abstract

PURPOSE: Chemical exchange saturation transfer MRI using an infusion of glucose (glucoCEST) is sensitive to the distribution of glucose in vivo; however, whether glucoCEST is more related to perfusion or glycolysis is still debatable. We compared glucoCEST to computed tomography perfusion (CTP), [18F] fluorodeoxyglucose positron emission tomography (FDG-PET), and hyperpolarized [1-13C] pyruvate magnetic resonance spectroscopy imaging (MRSI) in a C6 rat model of glioma to determine if glucoCEST is more strongly correlated with measurements of perfusion or glycolysis.
METHODS: 106 C6 glioma cells were implanted in Wistar rat brains (n = 11). CTP (including blood volume, BV; blood flow, BF; and permeability surface area product, PS) and FDG-PET standardized uptake value (SUV) were acquired at 11 to 13 days post-surgery. GlucoCEST measurements (∆CEST) were acquired the following day on a 9.4 T MRI before and after an infusion of glucose solution. This was followed by MRSI on a 3.0 T MRI after the injection of hyperpolarized [1-13C] pyruvate to generate regional maps of the lactate:pyruvate ratio (Lac:Pyr). Pearson's correlations between glucoCEST, CTP, FDG-PET, and Lac:Pyr ratio were evaluated.
RESULTS: Tumors had significantly higher SUV, BV, and PS than the contralateral brain. Tumor ∆CEST was most strongly correlated with CTP measurements of BV (ρ = 0.74, P = 0.01) and PS (ρ = 0.55, P = 0.04). No significant correlation was found between glycolysis measurements of SUV or Lac:Pyr with tumor ∆CEST. PS significantly correlated with SUV (ρ = 0.58, P = 0.005) and Lac:Pyr (ρ = 0.75, P = 0.005). BV significantly correlated with Lac:Pyr (ρ = 0.57, P = 0.02), and BF significantly correlated with SUV (ρ = 0.49, P = 0.02).
CONCLUSION: This study determined that glucoCEST is more strongly correlated to measurements of perfusion than glycolysis. GlucoCEST measurements have additional confounds, such as sensitivity to changing pH, that merit additional investigation.
© 2021. World Molecular Imaging Society.

Entities:  

Keywords:  FDG-PET; Glioblastoma; Tumor glycolysis; Tumor perfusion; glucoCEST; hyperpolarized [1-13C]pyruvate

Mesh:

Substances:

Year:  2021        PMID: 33534038     DOI: 10.1007/s11307-021-01585-1

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  30 in total

Review 1.  Malignant gliomas in adults.

Authors:  Patrick Y Wen; Santosh Kesari
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

Review 2.  Dynamic perfusion CT in brain tumors.

Authors:  Timothy Pok Chi Yeung; Glenn Bauman; Slav Yartsev; Enrico Fainardi; David Macdonald; Ting-Yim Lee
Journal:  Eur J Radiol       Date:  2015-02-23       Impact factor: 3.528

3.  In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma.

Authors:  Koji Sagiyama; Tomoyuki Mashimo; Osamu Togao; Vamsidhara Vemireddy; Kimmo J Hatanpaa; Elizabeth A Maher; Bruce E Mickey; Edward Pan; A Dean Sherry; Robert M Bachoo; Masaya Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

4.  Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer.

Authors:  Kannie W Y Chan; Michael T McMahon; Yoshinori Kato; Guanshu Liu; Jeff W M Bulte; Zaver M Bhujwalla; Dmitri Artemov; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2012-10-16       Impact factor: 4.668

5.  Optimum lean body formulation for correction of standardized uptake value in PET imaging.

Authors:  Abdel K Tahari; David Chien; Javad R Azadi; Richard L Wahl
Journal:  J Nucl Med       Date:  2014-06-24       Impact factor: 10.057

Review 6.  Angiogenesis in brain tumours.

Authors:  Rakesh K Jain; Emmanuelle di Tomaso; Dan G Duda; Jay S Loeffler; A Gregory Sorensen; Tracy T Batchelor
Journal:  Nat Rev Neurosci       Date:  2007-08       Impact factor: 34.870

Review 7.  Nuts and bolts of chemical exchange saturation transfer MRI.

Authors:  Guanshu Liu; Xiaolei Song; Kannie W Y Chan; Michael T McMahon
Journal:  NMR Biomed       Date:  2013-01-10       Impact factor: 4.044

8.  In vivo imaging of glucose uptake and metabolism in tumors.

Authors:  Simon Walker-Samuel; Rajiv Ramasawmy; Francisco Torrealdea; Marilena Rega; Vineeth Rajkumar; S Peter Johnson; Simon Richardson; Miguel Gonçalves; Harold G Parkes; Erik Arstad; David L Thomas; R Barbara Pedley; Mark F Lythgoe; Xavier Golay
Journal:  Nat Med       Date:  2013-07-07       Impact factor: 53.440

9.  Evaluation of CT Perfusion Biomarkers of Tumor Hypoxia.

Authors:  Qi Qi; Timothy Pok Chi Yeung; Ting-Yim Lee; Glenn Bauman; Cathie Crukley; Laura Morrison; Lisa Hoffman; Slav Yartsev
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

10.  Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients.

Authors:  Xiang Xu; Nirbhay N Yadav; Linda Knutsson; Jun Hua; Rita Kalyani; Erica Hall; John Laterra; Jaishri Blakeley; Roy Strowd; Martin Pomper; Peter Barker; Kannie Chan; Guanshu Liu; Michael T McMahon; Robert D Stevens; Peter C M van Zijl
Journal:  Tomography       Date:  2015-12
View more
  1 in total

1.  In vitro and in vivo comparison of MRI chemical exchange saturation transfer (CEST) properties between native glucose and 3-O-Methyl-D-glucose in a murine tumor model.

Authors:  Annasofia Anemone; Martina Capozza; Francesca Arena; Sara Zullino; Paola Bardini; Enzo Terreno; Dario Livio Longo; Silvio Aime
Journal:  NMR Biomed       Date:  2021-08-22       Impact factor: 4.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.